Replies to post #22231 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

“OxyContin may be the poster child, but it’s not the only opioid with the potential to be abused or to, in fact, be abused and cause serious problems.”

http://www.theglobeandmail.com/news/national/leadership-behind-canadian-medical-marijuana-company-has-an-oxycontin-past/article33200287/

[doogdilinger]

Exactly Angelo...no-one knows what's going on behind the scenes...but 1 thing's for certain is that Purdue hears all the footsteps coming and has the wherewithal to find and secure the perfect solution.

Dot connecting speculation is fun!

[Tekterra]

I've thought the same thing too. I thought Purdue was interested in IPCI platform. They knew they have to do something to protect their market. So it's either doing in house R&D or shop around.

If you look around how many companies are developing abuse deterrent tech? Not that many. The big pharma that have stuff approved is already competing against Purdue in the market. Not much choices left for the smaller developing companies that showed promise.

We might be right on here that FDA acceptance could mean a potential partnership with Purdue. Although acceptance doesn't mean approval but it at least establish the fact that FDA was happy with what IPCI presented to them for review.

I get the feeling Purdue is going to make a move in acquisition so it is wise to be holding companies like IPCI that has potential for a deal with Purdue or a take over.